The current status and future impact of targeted therapies in non-Hodgkin lymphoma.
about
The development of immunoconjugates for targeted cancer therapyNovel Drugs in Follicular LymphomaLenalidomide for the treatment of B-cell lymphoma.Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity.Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients.Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin LymphomaObinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic lA comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment.Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.
P2860
Q27021990-ACC5E077-10BB-4E99-8B9E-D94047AEE867Q28076335-633C20DD-EF7A-48CB-9F7E-56D5AC759B29Q30249007-9E78EC70-4033-4F85-9D10-79FFA8BACCF8Q35918821-A83BDAB0-D018-4B1D-BD4B-1FB65A9586E8Q38356369-5D8BD2B4-262E-4AFE-9225-2A30289DA69BQ38551337-7C1B5F2E-31E3-48D2-A44A-36300BC97719Q38827600-A3C77396-61E3-4421-A213-4DA46EAAFD67Q49177202-2647A94B-1A68-431B-80EC-C62BAAFBE151Q55052715-2233EA14-2D84-4622-8D4B-0A36292E7CC7
P2860
The current status and future impact of targeted therapies in non-Hodgkin lymphoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The current status and future impact of targeted therapies in non-Hodgkin lymphoma.
@en
type
label
The current status and future impact of targeted therapies in non-Hodgkin lymphoma.
@en
prefLabel
The current status and future impact of targeted therapies in non-Hodgkin lymphoma.
@en
P2860
P356
P1476
The current status and future impact of targeted therapies in non-Hodgkin lymphoma.
@en
P2093
Bruce D Cheson
Chaitra Ujjani
P2860
P304
191-202; quiz 203
P356
10.1586/EHM.13.6
P577
2013-04-01T00:00:00Z